Interferon alfa-2a
Drug timelines are a Plus or Pro feature.
10 regulatory and trial events tracked for Interferon alfa-2a, covering 2007-04-27 to 2022-03-10. Get the full timeline:
Most recent: Clinical Trial Update: Pazopanib in Combination With Interferon Alfa 2-A, in Patients With Advanced Renal Cell Carcinoma [Phase 1, Phase 2]